Medtronic Endeavors To Gain Drug-Eluting Stent Share In Europe
This article was originally published in The Gray Sheet
Executive Summary
Medtronic's ability to immediately launch 80,000Endeavor drug-eluting stents should help the firm to avoid the supply constraint issues faced by J&J